A Phase II Study of Neo-Adjuvant Cisplatin, Gemcitabine & Bevacizumab, Followed by Radical Cystectomy for Patients With Muscle Invasive, Resectable, Non-Metastatic Transitional Cell Carcinoma (TCC) of the Bladder.
Phase of Trial: Phase II
Latest Information Update: 27 Apr 2012
At a glance
- Drugs Bevacizumab; Cisplatin; Gemcitabine; Paclitaxel
- Indications Bladder cancer
- Focus Therapeutic Use
- 27 Apr 2012 Actual end date (Apr 2012) added as reported by ClinicalTrials.gov.
- 27 Apr 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 20 Nov 2006 New trial record.